Successful treatment of persistent and severe SARS‐CoV‐2 infection in a high‐risk chronic lymphocytic leukemia patient using Ronapreve™ antibodies

Successful treatment of persistent and severe SARS‐CoV‐2 infection in a high‐risk chronic lymphocytic leukemia patient using Ronapreve™ antibodies

Abstract Patients with lymphoproliferative diseases are at an increased risk of an incomplete immune response following vaccination or SARS‐CoV‐2 infection and might develop persistent viral infection and severe COVID‐19 disease. We present a case of successful treatment of persistent and mechanical...

Full description

Bibliographic Details
Main Authors: Fernanda Braga Seganfredo, Ana Raquel Dias, Pedro R. Santos, Marta Rebelo, Cristina João, Dina Mendes, Eduarda Carmo
Format: Article
Language:English
Published: Wiley 2022-11-01
Series:Clinical Case Reports
Subjects:
Casirivimab and Imdevimab
COVID‐19
haemato‐oncological patients
immunity
Online Access:https://doi.org/10.1002/ccr3.6548

Similar Items

Similar Items